Amino acid levels and nutritional outcomes in children with hereditary tyrosinemia type 1

被引：0
|
作者：
Brockett, J. [1 ,2 ]
Evans, M. [1 ]
Allender, B. [1 ,2 ]
Pandithan, D. [1 ]
机构：
[1] Royal Childrens Hosp, Dept Metab Med, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Dept Nutr & Food Serv, Melbourne, Vic, Australia
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷
关键词：
D O I：
10.1016/j.ymgme.2024.108371
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P.5
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [31] CLINICAL FEATURES, GENETIC SPECTRUM, AND OUTCOMES OF HEREDITARY TYROSINEMIA TYPE 1: A MULTICENTER STUDY FROM SOUTHEASTERN TÜRKIYE
    Goksoy, Emine
    Bozaci, Ayse ERGuL
    Gurbuz, Berrak B. I. L. G. I. N. E. R.
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2025, 26 (01): : 33 - 41
  • [32] Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1
    Ates, Ilayda
    Stuart, Callie
    Rathbone, Tanner
    Barzi, Mercedes
    He, Gordon
    Major, Angela M.
    Shankar, Vijay
    Lyman, Rachel A.
    Angner, Sidney S.
    Mackay, Trudy F. C.
    Srinivasan, Shanthi
    Farris, Alton Brad
    Bissig, Karl-Dimiter
    Cottle, Renee N.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (05)
  • [33] Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
    Park, Hyung-Doo
    Lee, Dong Hwan
    Choi, Tae-Youn
    Lee, You Kyoung
    Kim, Jong-Won
    Ki, Chang-Seok
    Lee, Yong-Wha
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (08) : 930 - 933
  • [34] In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type 1
    Labie, D
    M S-MEDECINE SCIENCES, 2000, 16 (03): : 419 - 420
  • [35] Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1
    Maiorana, A.
    Malamisura, M.
    Emma, F.
    Boenzi, S.
    Di Ciommo, V. M.
    Dionisi-Vici, C.
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (03) : 188 - 193
  • [36] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Ayse Cigdem Aktuglu Zeybek
    Ertugrul Kiykim
    Salim Neselioglu
    Halise Zeynep Iscan
    Tanyel Zubarioglu
    Mehmet Serif Cansever
    Ozcan Erel
    Pediatric Research, 2022, 92 : 474 - 479
  • [37] Waddling gait and invalidating rickets as presenting signs of hereditary tyrosinemia type 1
    Rigante, D
    Holme, E
    Segni, G
    Stabile, A
    Caradonna, P
    BONE, 2001, 28 (05) : S119 - S119
  • [38] Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways
    van Dyk, E.
    Steenkamp, A.
    Koekemoer, G.
    Pretorius, P. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (01) : 32 - 36
  • [39] Preclinical Assessment of an In Vivo Lentiviral Vector Cure for Hereditary Tyrosinemia Type 1
    Kaiser, Robert A.
    Nicolas, Clara T.
    Allen, Kari L.
    VanLith, Caitlin J.
    Du, Zeji
    Hillin, Lori G.
    Cao, William
    Bhagwate, Aditya
    O'Brien, Daniel
    Kocher, Jean-Pierre
    Hickey, Raymond D.
    Mondal, Gourish
    Lillegard, Joseph B.
    MOLECULAR THERAPY, 2020, 28 (04) : 426 - 426
  • [40] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Zeybek, Ayse Cigdem Aktuglu
    Kiykim, Ertugrul
    Neselioglu, Salim
    Iscan, Halise Zeynep
    Zubarioglu, Tanyel
    Cansever, Mehmet Serif
    Erel, Ozcan
    PEDIATRIC RESEARCH, 2022, 92 (02) : 474 - 479
12345